Inferra AI / Company / ALHC
Alignment Healthcare, Inc.
ALHC · Health Care
Last earnings Oct 29, 2026
Key results
Total revenuequarter
$993.7 million
Total revenue was $993.7 million, up 43.5% year-over-year Adjusted gross profit* was $127.5 million and income from operations was $7.7 million Adjusted gross profit excludes depreciation and amortization of $8.0 million and selling, general
SEC original ↗Alignment Healthcare, Inc. — Earnings release (8-K exhibit)EX-99Oct 30, 2025
Growthquarter
up 43.5%
Total revenue was $993.7 million, up 43.5% year-over-year Adjusted gross profit* was $127.5 million and income from operations was $7.7 million Adjusted gross profit excludes depreciation and amortization of $8.0 million and selling, general
SEC original ↗Alignment Healthcare, Inc. — Earnings release (8-K exhibit)EX-99Oct 30, 2025
Net incomequarter
$3.7 million
net income was $3.7 million * Please see "Third Quarter 2025 Non-GAAP Reconciliation Tables" below for more information on the non-GAAP financial measures reported here as supplemental information.
SEC original ↗Alignment Healthcare, Inc. — Earnings release (8-K exhibit)EX-99Oct 30, 2025
$ 3,729 $ (26,413 ) $ 10,282 $ (96,944 ) Net income (loss) per share attributable to Alignment Healthcare, Inc.
SEC original ↗Alignment Healthcare, Inc. — Earnings release (8-K exhibit)EX-99Oct 30, 2025
AI analysis
Q3 2025 · reported Oct 30, 2025
Based on: Earnings release + parent 8-K — transcript not held
The quarter in charts
Guidance ladder — revenue
Delivered vs the company's guided range
EX-99 · Oct 30, 2025 Guide as stated by the company; range and midpoint computed from the stated figure.
Headline figures
| Metric | Q3 2025 | Prior qtr | Year ago |
|---|---|---|---|
| Total revenue | $993.7 million | $1,015.3 million | — |
| Growth | up 43.5% | up 49.0% | — |
| Net income | $3.7 million | $15.7 million | — |
Guidance · company-stated
Direction: Raised
“htm PRESS RELEASE EdgarFiling EXHIBIT 99.1 Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics Reports Q3 revenue of $993.7 million, up 43.5% year-over-year Beats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit and adjusted EBITDA Has 100% of members in plans rated 4 stars or higher for second consecutive year in 2026, including two 5-star contracts in Nevada and North Carolina and a 4.5-star contract in Texas ORANGE, Calif.”
Classified from the release's primary full-year outlook statement.
What changed vs last quarter
- Guide midpoint vs latest-quarter revenue 0.0% computed from stated figures
Company-stated claims
Forward-looking · 30% compound annual growth rate · subscribers_users
“We have grown Health Plan Membership, which we define as members enrolled in our health maintenance organization ("HMO") and preferred provider organization ("PPO") contracts (the "Alignment Health Plan"), from approximately 13,000 at inception to 236,300 as of December 31, 2025, representing a 30% compound annual growth rate.”
10-K · Feb 27, 2026Event summary
Our third quarter results mark the third consecutive quarter in which we surpassed the high end of our guidance across all key metrics, said John Kao, founder and CEO
Based on: Earnings release + parent 8-K — transcript not held
Guidance & outlook
Direction: Raised
Revenue: “htm PRESS RELEASE EdgarFiling EXHIBIT 99.1 Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics Reports Q3 revenue of $993.7 million, up 43.5% year-over-year Beats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit and adjusted EBITDA Has 100% of members in plans rated 4 stars or higher for second consecutive year in 2026, including two 5-star contracts in Nevada and North Carolina and a 4.5-star contract in Texas ORANGE, Calif.”
Revenue — Raised (“raises”)
“htm PRESS RELEASE EdgarFiling EXHIBIT 99.1 Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics Reports Q3 revenue of $993.7 million, up 43.5% year-over-year Beats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit and adjusted EBITDA Has 100% of members in plans rated 4 stars or higher for second consecutive year in 2026, including two 5-star contracts in Nevada and North Carolina and a 4.5-star contract in Texas ORANGE, Calif.”
Classified from the release's primary full-year outlook statement.
Strategy & priorities
With 100% of our members in 4-star or higher plans for the second year in a row, we are leading a paradigm shift in Medicare Advantage that prioritizes quality, access and putting seniors first.
SEC original ↗Alignment Healthcare, Inc. — Earnings release (8-K exhibit)EX-99Oct 30, 2025
(5) Represents litigation costs considered outside of the ordinary course of business based on the following considerations which we assess regularly: (i) the frequency of similar cases that have been brought to date, or are expected to be brought within two years, (ii) complexity of the case, (iii) nature of the remedies sought, (iv) litigation posture of the Company, (v) counterparty involved, and (vi) the Company's overall litigation strategy.
SEC original ↗Alignment Healthcare, Inc. — Earnings release (8-K exhibit)EX-99Oct 30, 2025
Risks & headwinds
We cannot provide estimated ranges for the most directly comparable GAAP measures without unreasonable efforts because of the uncertainty around certain items that may impact such GAAP measures, including equity-based compensation expense and depreciation and amortization, that are not within our control or cannot be reasonably predicted.
SEC original ↗Alignment Healthcare, Inc. — Earnings release (8-K exhibit)EX-99Oct 30, 2025
(5) Represents litigation costs considered outside of the ordinary course of business based on the following considerations which we assess regularly: (i) the frequency of similar cases that have been brought to date, or are expected to be brought within two years, (ii) complexity of the case, (iii) nature of the remedies sought, (iv) litigation posture of the Company, (v) counterparty involved, and (vi) the Company's overall litigation strategy.
SEC original ↗Alignment Healthcare, Inc. — Earnings release (8-K exhibit)EX-99Oct 30, 2025
Forward-looking statements are subject to risks and uncertainties and are based on assumptions that may prove to be inaccurate, which could cause actual results to differ materially from those expected or implied by the forward-looking statements.
SEC original ↗Alignment Healthcare, Inc. — Earnings release (8-K exhibit)EX-99Oct 30, 2025
Adjusted EBITDA Adjusted EBITDA is a non-GAAP financial measure that we define as net income (loss) before interest expense, income taxes, depreciation and amortization expense, certain litigation costs, gains or losses on right of use ("ROU") assets, gains or losses on sale of property and equipment, restructuring costs and equity-based compensation expense.
SEC original ↗Alignment Healthcare, Inc. — Earnings release (8-K exhibit)EX-99Oct 30, 2025
What changed vs prior quarter
Guidance direction — prior quarter: Raised; this quarter: Raised
SEC original ↗Alignment Healthcare, Inc. — Earnings release (8-K exhibit)EX-99Oct 30, 2025
Total revenue — prior quarter passage and this quarter's passage are both cited.
SEC original ↗Alignment Healthcare, Inc. — Earnings release (8-K exhibit)EX-99Oct 30, 2025
Net income — prior quarter passage and this quarter's passage are both cited.
SEC original ↗Alignment Healthcare, Inc. — Earnings release (8-K exhibit)EX-99Oct 30, 2025
Earnings deck slides
0 decks with slide viewAlignment Healthcare, Inc. — Presentation / slide deck (8-K exhibit) — Slide view unavailable — this deck was filed as a web document, whose text has no page boundaries.
Competitors
Competitors & peers
Same GICS sector — classification peers, not declared competitors
Filings
32 documents- Q3 2026
- 8-KALHC
Oct 29, 2026
- 8-KALHC
- Q2 2026
- 8-KALHC
Jul 30, 2026
- 10-QALHC
- Q1 2026
- 8-KALHC
- 8-KALHC
May 12, 2026
- 8-KALHC
Apr 30, 2026
- 10-QALHC
- Q4 2025
- 8-KALHC
- 10-KALHC
Feb 27, 2026
- 8-KALHC
Feb 26, 2026
- 8-KALHC
Jan 12, 2026
- EX-99ALHC
- Q3 2025
- 8-KALHC
Oct 30, 2025
- 10-QALHC
- Q2 2025
- 8-KALHC
- 8-KALHC
Jul 30, 2025
- 10-QALHC
- Q1 2025
- 8-KALHC
Jun 11, 2025
- 8-KALHC
- 10-QALHC
- 8-KALHC
Apr 15, 2025
- 8-KALHC
Apr 11, 2025
- Q4 2024
- 8-KALHC
Feb 27, 2025
- 10-KALHC
Feb 27, 2025
- 8-KALHC
Jan 13, 2025
- Q3 2024
- 8-KALHC
Nov 25, 2024
- 8-KALHC
Nov 15, 2024
- 8-KALHC
Oct 29, 2024
- 10-QALHC
- Q2 2024
- 8-KALHC
Aug 16, 2024
- 10-QALHC
Earnings releases
10 documentsPresentations
1 document- Q4 2025
- ALHCDeck
Transcripts
0 documentsNo transcripts for Alignment Healthcare, Inc. are held in this edition of the library.
See also the earnings calendar for every tracked company’s next earnings date.